Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.45 |
| ▸ | ACACA | Q13085 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GCK | P35557 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11152390 | 0.83 | TBXAS1 (0.40) | ACACBACACAMEN1KMT2AGCK | |
| SCHEMBL16693263 | 0.83 | GCK (0.35) | MEN1KMT2AGCK | |
| SCHEMBL16685353 | 0.83 | GCK (0.35) | MEN1KMT2AGCK | |
| SCHEMBL23023778 | 0.81 | MEN1 (0.33) | MEN1KMT2AGCK | |
| SCHEMBL16685199 | 0.81 | MEN1 (0.33) | MEN1KMT2AGCK | |
| SCHEMBL12911516 | 0.79 | GCK (0.34) | MEN1KMT2AGCK | |
| SCHEMBL18047458 | 0.76 | GCK (0.35) | MEN1KMT2AGCK | |
| SCHEMBL16685525 | 0.76 | GCK (0.35) | MEN1KMT2AGCK | |
| SCHEMBL16693378 | 0.74 | GCK (0.31) | GCK | |
| SCHEMBL16685394 | 0.74 | GCK (0.31) | GCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3066102-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | Eisai R&D Management Co., Ltd. (JP) | 2016-09-14 | — | — | EP | disclosed |
| WO-2015066729-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-05-07 | — | — | WO | disclosed |